Press Releases Year None20212020201920182017 Turning Point Therapeutics to Participate in Upcoming Investor Conferences Mar 04, 2021 Turning Point Therapeutics Reports Fourth-Quarter and Full-Year Financial Results, Provides Operational Updates Mar 01, 2021 Turning Point Therapeutics to Host Fourth Quarter and Full-Year 2020 Conference Call Feb 18, 2021 Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days Feb 04, 2021 Turning Point Therapeutics Reports Updated Interim Data From Registrational Phase 2 Trident-1 Study of Repotrectinib in Patients With ROS1-Positive TKI-Naïve Non-Small Cell Lung Cancer Jan 29, 2021 Turning Point Therapeutics Announces 2021 Milestone Targets Jan 11, 2021 Turning Point and Zai Lab Broaden Collaboration Jan 11, 2021
Turning Point Therapeutics Reports Fourth-Quarter and Full-Year Financial Results, Provides Operational Updates Mar 01, 2021
Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days Feb 04, 2021
Turning Point Therapeutics Reports Updated Interim Data From Registrational Phase 2 Trident-1 Study of Repotrectinib in Patients With ROS1-Positive TKI-Naïve Non-Small Cell Lung Cancer Jan 29, 2021
